Germinal center B-cell–like diffuse large B-cell lymphomas (GCB-DLBCLs) show dependence on DOT1L and EZH2, with combined targeting offering potential as an alternative differentiation-based therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback